Yunping Song
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yunping Song has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Lingjing Jin
Department of Neurology and Neurological Rehabilitation, Shanghai Disabled Persons’ Federation Key Laboratory of Intelligent Rehabilitation Assistive Devices and Technologies, Yangzhi Rehabilitation Hospital (Shanghai Sunshine Rehabilitation Center), School of Medicine, Tongji University, Shanghai, China
4 shared publications Chenming Liu
Stem Cell Translational Research Center, Tongji Hospital, Tongji University School of Medicine, Shanghai, 200072, China
2 shared publicationsLingjing Jin
Department of Neurology and Neurological Rehabilitation, Shanghai Disabled Persons' Federation Key Laboratory of Intelligent Rehabilitation Assistive Devices and Technologies, Yangzhi Rehabilitation Hospital Affiliated to Tongji University, School of Medicine, Tongji University, Shanghai, China
2 shared publicationsRuoyu Li
Department of Neurology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China
2 shared publicationsDaniela Ragancokova
1 shared publicationFriedrich Schlesinger
1 shared publication
Latest Publications
- Open Access
- 30 September 2025
- Published by Springer Nature in BMC Medical Genomics
- Vol. 18 (1) , 1-16
Exploration and validation of the immune-related genes signatures and potential molecular mechanisms shared between Alzheimer’s disease (AD) and Parkinson’s disease (PD)
Alzheimer’s disease (AD) and Parkinson’s disease (PD) share neuroinflammatory features, yet their common immune-related mechanisms remain unclear. We integrated microarray datasets from AD/PD brain tissues to identify immune-related genes (IRGs). Hub genes were prioritized via protein-protein interaction (PPI) networks and validated using a Parkinson’s dementia (PDD) cohort and AD/PD mouse models. Functional enrichment, immune cell infiltration, and TF-miRNA networks were analyzed. Eleven hub IRGs (CXCR4, FLT1, SLIT1/2, SEMA3G/6D, etc.) were identified. CXCR4 and FLT1 exhibited significant upregulation in AD/PD patient brain tissues (AUC > 0.7, adjusted p-value of <0.05) and mouse model brain tissues (p < 0.05), correlating with cytokine signaling and axon guidance pathways. CXCR4 is uniquely associated with resting memory CD4+ T cells in both diseases, while FLT1 showed disease-specific immune interactions. A TF-miRNA network (39 TFs, 22 miRNAs) implicated CREB1 and STAT1/3 as key regulators. CXCR4 and FLT1 are pivotal shared immune hubs in AD/PD, linked to T-cell dysregulation and neuroinflammation. These findings highlight potential therapeutic targets and biomarkers for neurodegenerative comorbidity.
- 30 September 2025
- Published by Springer Nature in BMC Medical Genomics
- Vol. 18 (1) , 1-16
Open AccessExploration and validation of the immune-related genes signatures and potential molecular mechanisms shared between Alzheimer’s disease (AD) and Parkinson’s disease (PD)
Alzheimer’s disease (AD) and Parkinson’s disease (PD) share neuroinflammatory features, yet their common immune-related mechanisms remain unclear. We integrated microarray datasets from AD/PD brain tissues to identify immune-related genes (IRGs). Hub genes were prioritized via protein-protein interaction (PPI) networks and validated using a Parkinson’s dementia (PDD) cohort and AD/PD mouse models. Functional enrichment, immune cell infiltration, and TF-miRNA networks were analyzed. Eleven hub IRGs (CXCR4, FLT1, SLIT1/2, SEMA3G/6D, etc.) were identified. CXCR4 and FLT1 exhibited significant upregulation in AD/PD patient brain tissues (AUC > 0.7, adjusted p-value of <0.05) and mouse model brain tissues (p < 0.05), correlating with cytokine signaling and axon guidance pathways. CXCR4 is uniquely associated with resting memory CD4+ T cells in both diseases, while FLT1 showed disease-specific immune interactions. A TF-miRNA network (39 TFs, 22 miRNAs) implicated CREB1 and STAT1/3 as key regulators. CXCR4 and FLT1 are pivotal shared immune hubs in AD/PD, linked to T-cell dysregulation and neuroinflammation. These findings highlight potential therapeutic targets and biomarkers for neurodegenerative comorbidity.
- 31 May 2025
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1871 (7) , 167928
Microglia-drive IRF8 upregulates complement pathway in Parkinson's disease
- 31 May 2025
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1871 (7) , 167928
Microglia-drive IRF8 upregulates complement pathway in Parkinson's disease
- Open Access
- 1 January 2025
- Published by Wiley in Behavioural Neurology
- Vol. 2025 (1)
Intelligent Assessment Techniques for Abnormal Movement Patterns in Neurological Disorders: Applications and Advances
Neurological disorders frequently result in diverse forms of abnormal movement. Conventional clinical assessment approaches often lack the precision and objectivity needed to evaluate muscle involvement and associated functional limitations. With the development of various intelligent assessment devices, technologies such as wearable sensors, motion capture, radar, and imaging technology, which are based on myoelectricity, kinematics, mechanics, and optics, combined with mathematical models and algorithms, have been widely used for abnormal movement recognition. These technologies further improve the accuracy and validity of clinical evaluation. In this paper, we review the latest advances in intelligent technologies that help clinicians qualitatively and quantitatively assess abnormal movement patterns and carry out personalized rehabilitation treatment. Our work was also aimed at summarizing the research and application of intelligent assessment techniques.
- 1 January 2025
- Published by Wiley in Behavioural Neurology
- Vol. 2025 (1)
Open AccessIntelligent Assessment Techniques for Abnormal Movement Patterns in Neurological Disorders: Applications and Advances
Neurological disorders frequently result in diverse forms of abnormal movement. Conventional clinical assessment approaches often lack the precision and objectivity needed to evaluate muscle involvement and associated functional limitations. With the development of various intelligent assessment devices, technologies such as wearable sensors, motion capture, radar, and imaging technology, which are based on myoelectricity, kinematics, mechanics, and optics, combined with mathematical models and algorithms, have been widely used for abnormal movement recognition. These technologies further improve the accuracy and validity of clinical evaluation. In this paper, we review the latest advances in intelligent technologies that help clinicians qualitatively and quantitatively assess abnormal movement patterns and carry out personalized rehabilitation treatment. Our work was also aimed at summarizing the research and application of intelligent assessment techniques.
- Open Access
- 1 October 2024
- Published by Elsevier in Neurochemistry International
- Vol. 180, 105871
Vagus nerve stimulation with a small total charge transfer improves motor behavior and reduces neuroinflammation in a mouse model of Parkinson's disease
- 1 October 2024
- Published by Elsevier in Neurochemistry International
- Vol. 180, 105871
Open AccessVagus nerve stimulation with a small total charge transfer improves motor behavior and reduces neuroinflammation in a mouse model of Parkinson's disease
- Open Access
- 10 October 2023
- Published by Springer Nature in Research Square
Comprehensive analyses identify IRF8 in microglia as a possible regulatory target for Parkinson’s Disease
Parkinson's disease (PD) is a widespread degenerative disorder of the central nervous system. The gradual degeneration of dopaminergic neurons in the substantia nigra region is one of the primary pathological features of PD. Glial cells in SN are also linked to the pathological PD alterations. To discern the role of neurons and glial cells as well as their corresponding genetic modifications in PD, we utilized diverse bioinformatics techniques and performed biological experiments on cell and animal models. Several transcriptome datasets of the substantia nigra region were collected from the Gene Expression Omnibus dataset. Cibersort was used to deconvolute the data into proportions of brain cell types. WGCNA was used to analyze the association between modules and traits. Machine learning was used to select the hub genes from WGCNA results. Based on the results of transcriptome analysis, microglia were the most related cell type and IRF8 was identified as the hub gene associated with PD and microglia. Furthermore, an increased ratio of Irf8+ microglia was observed in PD mice, along with an elevated expression of Irf8 in primary microglia cultures treated with a-synuclein preformed fibril (PFFs). In conclusion, our research indicated IRF8 may be involved in the functional regulation of microglia in PD.
- 10 October 2023
- Published by Springer Nature in Research Square
Open AccessComprehensive analyses identify IRF8 in microglia as a possible regulatory target for Parkinson’s Disease
Parkinson's disease (PD) is a widespread degenerative disorder of the central nervous system. The gradual degeneration of dopaminergic neurons in the substantia nigra region is one of the primary pathological features of PD. Glial cells in SN are also linked to the pathological PD alterations. To discern the role of neurons and glial cells as well as their corresponding genetic modifications in PD, we utilized diverse bioinformatics techniques and performed biological experiments on cell and animal models. Several transcriptome datasets of the substantia nigra region were collected from the Gene Expression Omnibus dataset. Cibersort was used to deconvolute the data into proportions of brain cell types. WGCNA was used to analyze the association between modules and traits. Machine learning was used to select the hub genes from WGCNA results. Based on the results of transcriptome analysis, microglia were the most related cell type and IRF8 was identified as the hub gene associated with PD and microglia. Furthermore, an increased ratio of Irf8+ microglia was observed in PD mice, along with an elevated expression of Irf8 in primary microglia cultures treated with a-synuclein preformed fibril (PFFs). In conclusion, our research indicated IRF8 may be involved in the functional regulation of microglia in PD.
- 1 January 2022
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 132, 362-377
The relationship between allergic diseases and tic disorders: A systematic review and meta-analysis
- 1 January 2022
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 132, 362-377
The relationship between allergic diseases and tic disorders: A systematic review and meta-analysis
- 1 June 2010
- Published by Elsevier in European Journal of Pharmacology
- Vol. 636 (1-3) , 59-64
Changes in extracellular pH affect glycine receptor channels expressed in HEK 293 cells
- 1 June 2010
- Published by Elsevier in European Journal of Pharmacology
- Vol. 636 (1-3) , 59-64
Changes in extracellular pH affect glycine receptor channels expressed in HEK 293 cells